Immediate Impact
51 standout
Citing Papers
Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options
2025 Standout
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
Works of Li Shen being referenced
The farnesoid X receptor agonist EDP‐305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Li Shen | 100 | 115 | 93 | 159 | 38 | 553 | |
| Danuta Fedak | 105 | 81 | 63 | 138 | 43 | 599 | |
| Chiz-Tzung Chang | 122 | 88 | 63 | 195 | 32 | 629 | |
| Siyer Roohani | 142 | 109 | 77 | 174 | 34 | 589 | |
| Yunfeng Xia | 76 | 132 | 58 | 220 | 37 | 629 | |
| Subir R. Maitra | 142 | 108 | 137 | 180 | 29 | 605 | |
| Jingzhou Wang | 75 | 129 | 141 | 164 | 43 | 612 | |
| Alok R. Khandelwal | 78 | 96 | 68 | 187 | 39 | 625 | |
| Xiao Chen | 122 | 129 | 94 | 153 | 36 | 498 | |
| Monia Elasmi | 77 | 90 | 86 | 98 | 48 | 516 | |
| Parvin Amiri | 57 | 108 | 94 | 186 | 33 | 511 |
All Works
Login with ORCID to disown or claim papers
Loading papers...